Publications

5808 Results

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Authors
BP Schneider;L Li;F Shen;KD Miller;M Radovich;A O'Neill;RJ Gray;D Flockhart;G Jiang;Z Wang;D Lai;D Koller;H Pratt;C Dang;D Northfelt;E Perez;T Shenkier;M Cobleigh;ML Smith;E Railey;A Partridge;J Gralow;J Sparano;N Davidson;T Faroud;G Sledge
Journal / Conference
British Journal of Cancer 111(6):1241-1248;
Year
2014
Research Committee(s)
Breast
PMID
PMID25117820
PMC
PMC4453857
Study Number(s)
CTSU/E2100

Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk

Authors
AR Kristal;A Darke;JS Morris;C Tangen;P Goodman;L Minasian;H Parnes;S Lippman;E Klein
Journal / Conference
Journal of the National Cancer Institute 106(3):djt456;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID24563519
PMC
PMC3975165
Study Number(s)
S0000

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial

Authors
A Kristal;A Till;X Song;C Tangen;P Goodman;M Neuhouser;IM Thompson;F Meyskens;G Goodman;L Minasian;H Parnes;E Klein
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention 23(8):1494-1504;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID24732629
PMC
PMC4119495
Study Number(s)
S0000

SWOG S0910: A phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia

Authors
A Advani;S McDonough;S Coutre;B Wood;G Radich;M Mims;M O'Donnell;S Elkins;M Becker;M Othus;F Appelbaum
Journal / Conference
British Journal of Haematology May;165(4):504-509;
Year
2014
Research Committee(s)
Leukemia
PMID
PMID24579885
PMC
PMC4209396
Study Number(s)
S0910

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial

Authors
JM Schenk;C Till;CM Tangen;P Goodman;X Song;KC Torkko;AR Kristal;U Peters;M Neuhouser
Journal / Conference
Cancer Epidemiology, Biomarkers & Prevention 23(8):1484-1493;
Year
2014
Research Committee(s)
Cancer Control
PMID
PMID25085836
PMC
PMC4120235
Study Number(s)
SWOG-9217

Added value of genetic risk score to the Prostate Cancer Prevention Trial (PCPT) risk calculator: findings from the PCPT study

Authors
H Chen;J Sun;D Ankerst;C Tangen;WB Isaacs;SL Zheng;P Goodman;IM Thompson;E Platz;J Xu
Journal / Conference
American Urological Association Annual Meeting (May 16-21, 2014 Orlando, FL), abst. MP69-12; moderated poster session;
Year
2014
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

A functional variant in NKX3.1 associated with prostate cancer risk in the SELECT Trial

Authors
E Martinez;A Darke;C Tangen;P Goodman;J Fowke;EA Klein;S Abdulkadir
Journal / Conference
Cancer Prevention Research 7(9):950-957;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID24894197
PMC
PMC4154984
Study Number(s)
S0000

Statin drug use is not associated with prostate cancer risk in men who are regularly screened

Authors
E Platz;C Tangen;P Goodman;C Till;H Parnes;W Figg;D Albanes;M Neuhouser;E Klein;MS Lucia;IM Thompson;AR Kristal
Journal / Conference
Journal of Urology 192(2):379-384;
Year
2014
Research Committee(s)
Cancer Control
PMID
PMID24518774
PMC
PMC4104140
Study Number(s)
SWOG-9217

SWOG0919: a phase 2 study of idarubucin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia

Authors
A Advani;S McDonough;E Copelan;C Willman;D Mulford;A List;M Sekeres;M Othus;H Erba;F Appelbaum
Journal / Conference
British Journal of Haematology 167(2):233-237;
Year
2014
Research Committee(s)
Leukemia
PMID
PMID25039477
PMC
PMC4188732
Study Number(s)
S0919

Assessing needs of cancer patients (survivors) in providing follow-up cancer information

Authors
E Lackey;K Anderson;J Klemp;A Gottlieb;C Fabian
Journal / Conference
American Society of Preventive Oncology 2013 Annual Meeting (March 8-11, 2014, Arlington, VA), poster;
Year
2014
Research Committee(s)
Cancer Survivorship